RSS-Feed abonnieren
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0042-1758398
Stroke-related mortality analysis in Paraná, Brazil, over 10 years
Análise da mortalidade relacionada ao acidente vascular cerebral no estado do Paraná, Brasil, ao longo de 10 anos![](https://www.thieme-connect.de/media/10.1055-s-00054595/202211/lookinside/thumbnails/10-1055-s-0042-1758398_210338-1.jpg)
Abstract
Background Stroke is the second leading cause of death and disability around the world.
Objective The purpose of this study is to evaluate the age- and sex-specific mortality rates related to stroke in the state of Paraná, Brazil, between 2007 and 2016.
Methods In this cross-sectional study, residents in the state of Paraná were selected by death certificates (from 2007–2016); the basic cause of death was stroke. A descriptive analysis was performed, and mortality rates were calculated with a 95% confidence interval (95% CI) for each year.
Results From 2007 to 2016, there were 62,607 deaths in the state of Paraná due to stroke. Most individuals had medical assistance before death (85.7% in 2007 versus 83.9% in 2016), and most of these deaths occurred in hospitals (73.6% in 2007 versus 74.8% in 2016). Death rates due to stroke increased from 138 (95% CI 135–142) to 163 (95% CI 159–166) per 100,000 inhabitants. This raise occurred mainly in those over 79 years old. For the ages groups of 34 to 44 and 44 to 54 years, mortality rate decreased.
Conclusions In the past 15 years, despite the advances in the diagnosis and treatment of stroke, there has been an increase in mortality due to stroke in the state of Paraná. This fact is possibly associated with the aging of the population because there was a more pronounced increase in the group over 79 years old. Thus, new health strategies are necessary to improve the survival and quality of life of poststroke individuals.
Resumo
Antecedentes O acidente vascular cerebral (AVC) é a segunda principal causa de morte e invalidez em todo o mundo.
Objetivo O objetivo desse estudo é avaliar as taxas de mortalidade específicas por idade e sexo relacionadas ao AVC no estado do Paraná, Brasil, entre 2007 e 2016.
Métodos Neste estudo transversal, foram selecionados residentes no estado do Paraná por certidões de óbito (de 2007–2016); a causa básica da morte foi AVC. Uma análise descritiva foi realizada e as taxas de mortalidade calculadas com intervalo de confiança de 95% (IC 95%) para cada ano.
Resultados De 2007 a 2016, ocorreram 62.607 óbitos no estado do Paraná por AVC. A maioria dos indivíduos teve assistência médica antes do óbito (85,7% em 2007 contra 83,9% em 2016), e a maioria desses óbitos ocorreu em hospitais (73,6% em 2007 contra 74,8% em 2016). As taxas de mortalidade por AVC aumentaram de 138 (IC 95% 135–142) para 163 (IC 95% 159–166) por 100.000 habitantes. Esse aumento ocorreu principalmente em maiores de 79 anos. Para as faixas etárias de 34 a 44 e 44 a 54 anos, a taxa de mortalidade diminuiu.
Conclusões Nos últimos 15 anos, apesar dos avanços no diagnóstico e tratamento do AVC, houve aumento da mortalidade no estado do Paraná. Este fato está possivelmente associado ao envelhecimento da população, pois houve um aumento mais acentuado no grupo acima de 79 anos. Assim, novas estratégias de saúde são necessárias para melhorar a sobrevida e a qualidade de vida dos indivíduos pós-AVC.
Authors' Contributions
RDPD: conceived and designed the study, analyzed and interpreted data, wrote the article and reviewed it for intellectual and final approval of the completed manuscript; CLT: analyzed and interpreted data, wrote the article and reviewed it for intellectual and final approval of the completed manuscript; DPF, GSF: contributed with data acquisition, analyzed and interpreted data, wrote the article and reviewed it for intellectual and final approval of the completed manuscript; RHDC, FDNLN: analyzed and interpreted data and reviewed it for intellectual and final approval of the completed manuscript; VHFZ, MCL: conceived and designed the study and reviewed it for intellectual and final approval of the completed manuscript.
Publikationsverlauf
Eingereicht: 22. August 2021
Angenommen: 12. Dezember 2021
Artikel online veröffentlicht:
28. Dezember 2022
© 2022. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18 (05) 439-458
- 2 Donnan GA. Stroke around the world. Int J Stroke 2011; 6 (03) 181
- 3 Thrift AG, Thayabaranathan T, Howard G. et al. Global stroke statistics. Int J Stroke 2017; 12 (01) 13-32
- 4 Ouriques Martins SC, Sacks C, Hacke W. et al. Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurol 2019; 18 (07) 674-683
- 5 Borges GM. Health transition in Brazil: regional variations and divergence/convergence in mortality. Cad Saude Publica 2017; 33 (08) e00080316
- 6 Feigin VL, Vos T. Global Burden of Neurological Disorders: From Global Burden of Disease Estimates to Actions. Neuroepidemiology 2019; 52 (1-2): 1-2
- 7 Murray CJL, Lopez AD. Measuring global health: motivation and evolution of the Global Burden of Disease Study. Lancet 2017; 390 (10100): 1460-1464
- 8 Atlas do Desenvolvimento Humano do Brasil. Ranking Todo o Brasil,. www.atlasbrasil.org.br/ranking 2013 , accessed 13 July 2021).
- 9 IBGE. Instituto Brasileiro de Geografia e Estatística. Censo 2010. https://censo2010.ibge.gov.br/ (Accessed 13 July 2021).
- 10 Departamento de Informática do SUS. Informações em saúde,. www2.datasus.gov.br/DATASUS/ (2009, accessed 5 November 2020].
- 11 Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics 2011; 8 (03) 319-329
- 12 Yousufuddin M, Young N. Aging and ischemic stroke. Aging (Albany NY) 2019; 11 (09) 2542-2544
- 13 Nasri F. The aging population in Brazil. Einstein (Sao Paulo) 2008; 6 (01) S4-S6
- 14 Donkor ES. Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke Res Treat 2018; 2018: 3238165
- 15 Ministério da Saúde do Brasil. Saúde Brasil 2018 - Uma análise da situação de saúde e das doenças e agravos cronicos: desafios e perspectivas,. http://bvsms.saude.gov.br/bvs/publicacoes/saude_brasil_2018_analise_situacao_saude_doencas_agravos_cronicos_desafios_perspectivas.pdf (2019, accessed 23 October 2020).
- 16 Wassertheil-Smoller S, Kaplan RC, Salazar CR. Stroke findings in the Women's Health Initiative. Semin Reprod Med 2014; 32 (06) 438-446
- 17 Júnior M. Governo gasta R$ 3,89 ao dia na saúde de cada brasileiro,. https://portal.cfm.org.br/index.php?option=com_content&id=25985:2016-02-18-12-31-38 (2019, accessed 09 September 2020).
- 18 World Health Organization (Regional Committee for the Americas), Strategy for Universal Access to Health and Universal Health Coverage. 2014
- 19 Ducci RD, Lange MC, Zétola VHF, Rundek T. Factors Related to Cardioembolism as Major Predictors of Poor Survival after First-Ever Middle Cerebral Artery Stroke Treated with Thrombolysis. Cerebrovasc Dis 2017; 43 (3-4): 178-185
- 20 Mamed SN, Ramos AMO, Araújo VEM, Jesus WS, Ishitani LH, França EB. Profile of deaths from unspecified stroke after investigation of garbage codes in 60 cities in Brazil, 2017. Rev Bras Epidemiol 2019; 22 (22, Suppl 3) e190013, 3
- 21 Phan HT, Blizzard CL, Reeves MJ. et al. Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy): A Meta-Analysis of Individual Participant Data. Circ Cardiovasc Qual Outcomes 2017; 10 (02) e003436
- 22 Phan HT, Gall S, Blizzard CL. et al. Sex Differences in Causes of Death After Stroke: Evidence from a National, Prospective Registry. J Womens Health (Larchmt) 2021; 30 (03) 314-323
- 23 Laurenti R, Mello Jorge MHPD, Gotlieb SLD. A confiabilidade dos dados de mortalidade e morbidade por doenças crônicas não transmissíveis. Cien Saude Colet 2004; 9 (04) 909-920